A CRISPR Therapy Just Cured A Disease From Inside The Body For The First Time. The Gene-Editing Era Officially Started Monday ...

Intellia Therapeutics, a leading biotechnology company, announced that its CRISPR-based treatment for a rare swelling ...

CRISPR Therapeutics proved the strength of its technology a couple of years ago when it won approval for its first product.

Gene editing pioneers are working to transform one-off CRISPR treatments, like the therapy that saved Baby KJ, into scalable platforms capable of treating broader patient populations. Industry leaders ...

Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a ...

Berkeley—Nobel Laureate Jennifer Doudna, PhD, professor of biochemistry, biophysics, and structural biology at UC Berkeley, aspires for “CRISPR to become the standard of medical care for certain ...

The company's treatment for hereditary angioedema reduced attacks by 87% vs. placebo in a Phase 3 trial, clearing the way for ...

Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather than permanently altering the genome.

In a keynote talk during GEN’s “The State of CRISPR & Genome Editing” virtual summit, originally broadcast on June 11, 2025, Fyodor Urnov, PhD, Director, Technology & Translation, Innovative Genomics ...

Nicole and Kyle Muldoon with their child, KJ, who received a CRISPR gene editing therapy at Children's Hospital of Philadelphia. From the San Francisco Business Times. Months after helping manufacture ...